Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases.
Lo MK, Albariño CG, Perry JK, Chang S, Tchesnokov EP, Guerrero L, Chakrabarti A, Shrivastava-Ranjan P, Chatterjee P, McMullan LK, et al. Proc Natl Acad Sci U S A. 2020 Oct 27; 117(43):26946-26954. Epub 2020 Oct 7.